Celldex Therapeutics reported $18.15M in Cash and Equivalent for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbvie ABBV:US $ 8449M 559M
Agenus AGEN:US $ 114.14M 34.97M
Amgen AMGN:US $ 6266M 2821M
Aptinyx Inc APTX:US $ 103.81M 12.07M
Arena Pharmaceuticals ARNA:US $ 219.54M 240.6M
Bristol Myers Squibb BMY:US $ 14546M 4889M
Celldex Therapeutics CLDX:US $ 18.15M 49.88M
Glaxosmithkline GSK:US $ 6292M 2009M
Nektar Therapeutics NKTR:US $ 198.96M 143.11M
Newlink Genetics NLNK:US $ 105.58M 32.88M
Pfizer PFE:US $ 1784M 197M
Rigel Pharmaceuticals RIGL:US $ 36.57M 0.1M
Seattle Genetics SGEN:US $ 558.42M 361.03M